Map | A Partnership for Children's Health Search:  Advanced Search
Home General Information Country Support Board Task Forces Resources Media Center
About the Board Last Board Meeting Members Board Reports EC reports Private Access
Printer-friendly format

Quick Reference:

What is GAVI?

GAVI Fact Sheets


Board Documents


Press Releases

Immunization Information

Immunization Forum
Latest Issue

GAVI Update



Sixth GAVI Board Meeting, 17 October 2001, Ottawa, Canada

October 2001

5. China Memorandum of Understanding (MOU)


  • Development of an MOU with a country that has been approved for support by the GAVI Board will not become standard practice ­ it will only be explored under special circumstances, such as in large countries where the Vaccine Fund will be investing a large sum, and in those where the ICC thinks it is needed.

  • Concern was expressed that the Board had been under pressure to make a rapid decision in order to capture an opportunity for publicity that did not in the end materialise. It was suggested that due process should be followed in future.

  • The Board supported the proposed guidelines for the MOU with China developed by the sub-group (Mali, Norway, United Kingdom, CVP, GAVI Secretariat) which participated in a teleconference with China ICC representatives one day prior to the Board meeting. Accordingly, the MOU should cover the following points:

    • AD syringes: The MOH proposal that the central government will contribute hepatitis B vaccine and related syringe costs, but that counties will contribute to the cost of syringes for the other EPI vaccines, is acceptable.

    • Procurement: The MOH proposal of using an open, national competitive tenders managed by MOH and MOF is acceptable. It might be advisable to include a procurement specialist in the process.

    • User fees: The Board will accept that China will charge a low service fee for hepatitis B, in line with the fee charged for other EPI vaccines. It hopes that such service fee will eventually be phased out.

    • Implementation arrangements, including:

      • that the ICC will monitor immunization generally, not just GAVI supported aspects

      • the need for accountability and independent auditing

      • the need for county level implementation plans

      • monitoring arrangements that maximize the use of existing health information systems

      • roles and reporting arrangements for the project office and manager

      • the need to address disposal of AD syringes

  • There are four basic options for whom should sign the MOU on behalf of GAVI: a designated member of the Board, the Chair of the Board, the President of the Vaccine Fund, or the Executive Secretary of the Secretariat.


The Board:

5.1 requested that the MOU with China be developed based on the guidelines presented and be approved by the Board before finalization.

5.2 agreed that UNICEF would submit a proposal to the Board for the most appropriate signatories for the MOU on behalf of GAVI.


[ star_int ]   Contact us | Guestbook | Copyrights | Illustrated site